Previous studies have shown that ALDH1A2 is a candidate tumor suppressor gene in ovarian cancer and enhancing ALDH1A2-linked signaling might provide new opportunities for therapeutic intervention (Choi et al. 2019). The gene discussed is ALDH1A2; the disease is ovarian carcinoma.